≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_GUM_EXALLC for full statistics.

Malignant neoplasm of gum

Endpoint Browser

C3_GUM

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C03
  • Cause of death: ICD-9 — 143
  • Cause of death: ICD-8 — 143
  • Cancer registry: Topography ICD-O-3 — C03
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

136

4. Check minimum number of events

None

136

5. Include endpoints

None

136

6. Filter based on genotype QC (FinnGen only)

136

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
5
First used in FinnGen datafreeze
DF9

Similar endpoints

↥

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 136 62 74
Unadjusted period prevalence (%) 0.03 0.02 0.03
Median age at first event (years) 70.05 72.74 67.80

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
124
Matched controls
1240
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
+∞
113.7
91
*
8070/3-C03.1
ICD-O-3
Squamous cell carcinoma, NOS, of lower gum
+∞
76.1
65
*
EDB00
NOMESCO Finland
Partial excision of mandible
+∞
74.7
64
*
ECA20
NOMESCO Finland
Biopsy of gingiva
358.1
72.8
67
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
427.0
54.8
51
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
101.2
50.4
53
9
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
686.3
48.9
45
*
130
Kela drug reimbursment
Malignant tumour
26.2
47.7
72
62
GBB00
NOMESCO Finland
Tracheostomy
91.7
46.8
50
9
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
617.1
45.3
42
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
21.1
45.3
76
86
SAA03
NOMESCO Finland
Extended examination of mouth
22.2
44.2
109
305
JDB10
NOMESCO Finland
Percutaneous gastrostomy
63.1
44.0
50
13
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
82.9
43.3
47
9
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
17.0
40.9
103
277
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
37.4
34
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
31.3
33.7
45
22
WF003
NOMESCO Finland
Adjuvant radiotherapy
38.6
31.8
40
15
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
36.2
31.3
40
16
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
88.8
30.7
33
5
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
22.8
30.4
45
30
EKA10
NOMESCO Finland
Biopsy of cheek
43.1
30.3
37
12
EBB10
NOMESCO Finland
Insertion of dental implant
66.1
30.3
34
7
8070/3-C03.0
ICD-O-3
Squamous cell carcinoma, NOS, of upper Gum
+∞
29.3
27
*
SBB10
NOMESCO Finland
Teeth copy
18.4
28.0
45
37
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
10.0
27.2
65
123
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
19.2
26.2
41
31
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
89.4
26.0
28
*
ZZQ20
NOMESCO Finland
Free microvascular graft of skin, muscle and bone
+∞
25.9
24
*
EBB15
NOMESCO Finland
Insertion of dental implant abutment
162.8
25.7
26
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
29.4
24.6
33
15
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
16.2
23.4
39
34
WX110
NOMESCO Finland
Local anesthesy
12.1
22.5
114
601
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
42.5
22.2
27
8
EBA15
NOMESCO Finland
Extraction of large number of teeth
19.1
21.4
33
23
WX408
NOMESCO Finland
General anesthesy, balanced
6.5
20.7
76
244
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
88.1
20.4
22
*
A07AA02
ATC
nystatin; oral
12.6
20.3
38
42
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
6.2
19.6
90
371
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
19.3
18
*
EEB00
NOMESCO Finland
Partial excision of maxilla
222.2
19.1
19
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
12.7
19.0
35
37
EP1AE
NOMESCO Finland
Neck ultrasound examination
13.3
19.0
34
34
SAA04
NOMESCO Finland
Special inverstigation of mouth
15.0
18.9
32
28
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
62.5
18.6
21
*
ZXE90
NOMESCO Finland
More than 22 hours
104.4
17.0
18
*
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
104.4
17.0
18
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.9
16.9
57
155
K13.78
ICD-10 Finland
Other change in the oral mucosa
25.3
16.7
23
11
K13.29
ICD-10 Finland
Indefinite leukoplakia
55.5
16.5
19
*
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
13.2
16.3
29
28
SBA00
NOMESCO Finland
Microbiological examinations
26.4
16.2
22
10
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
31.2
16.2
21
8
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
97.7
16.0
17
*
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
182.0
15.9
16
*
EHA10
NOMESCO Finland
Biopsy of palate
52.1
15.5
18
*
XF612
NOMESCO Finland
Measurement of central venous pressure
+∞
14.9
14
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
18.8
14.6
22
14
SXC03
NOMESCO Finland
Other oral or dental procedure
34.7
14.3
18
6
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
60.7
14.2
16
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
11.9
14.1
26
27
R4190
NOMESCO Finland
Nutritional therapy
16.4
13.9
22
16
C03.9
ICD-10 Finland
Malignant neoplasm: Gum, unspecified
+∞
13.8
13
*
EEB10
NOMESCO Finland
Maxillectomy
+∞
13.8
13
*
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
56.4
13.2
15
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
56.4
13.2
15
*
N02AA05
ATC
oxycodone; systemic
5.0
12.7
47
134
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
12.7
12
*
EDB20
NOMESCO Finland
Hemimandibulectomy
+∞
12.7
12
*
WX872
NOMESCO Finland
Intensive care
9.0
12.6
27
37
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
42.2
12.5
15
*
L43.8
ICD-10 Finland
Other lichen planus
42.2
12.5
15
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
52.1
12.2
14
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
17.3
11.7
18
12
C06.9
ICD-10 Finland
Malignant neoplasm: Mouth, unspecified
+∞
11.6
11
*
EDC42
NOMESCO Finland
Mandibular repair with implant
+∞
11.6
11
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
10.9
11.6
22
24
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
9.3
11.6
24
31
SPF20
NOMESCO Finland
Temporary soling for filling
28.1
11.4
15
6
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
28.1
11.4
15
6
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
7.7
11.1
26
41
WZC30
NOMESCO Finland
Teaching
5.3
11.0
36
88
K13.20
ICD-10 Finland
Idiopathic leukoplakia
65.8
10.8
12
*
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
65.8
10.8
12
*
TEA00
NOMESCO Finland
Biopsy of lip
65.8
10.8
12
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.7
10.6
32
71
RS316
NOMESCO Finland
NA
119.7
10.6
11
*
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
+∞
10.6
10
*
SAA01
NOMESCO Finland
Simple examination of mouth
4.0
10.3
99
615
K05.31
ICD-10 Finland
Periodontitis pronounced
5.9
10.3
30
64
Z2446
NOMESCO Finland
Social worker
7.2
10.2
25
42
R4110
NOMESCO Finland
Physiotherapy
3.6
10.1
60
255
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.5
10.0
81
434
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
7.4
10.0
24
39
ECA35
NOMESCO Finland
Complicated excision of lesion of gingiva
59.8
9.8
11
*
ZZA00
NOMESCO Finland
Split skin graft
10.0
9.7
19
22
SXA10
NOMESCO Finland
Epithel biopsy of mouth
19.5
9.7
14
8
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
12.1
9.6
17
16
EB1WA
NOMESCO Finland
NA
107.9
9.6
10
*
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
+∞
9.5
9
*
K05.30
ICD-10 Finland
Periodontitis complex
4.7
9.3
34
93
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
9.1
9.3
19
24
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
39.9
9.2
11
*
EBA00
NOMESCO Finland
Extraction of tooth
3.4
9.1
58
255
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.8
8.9
45
163
ZX090
NOMESCO Finland
Other technic of radiotherapy
11.3
8.8
16
16
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
53.9
8.8
10
*
WF002
NOMESCO Finland
Radical radiotherapy
8.1
8.7
19
27
EKB00
NOMESCO Finland
Excision of lesion of cheek
29.9
8.6
11
*
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
3.3
8.6
58
262
C06.21
ICD-10 Finland
Malignant tumor of the lower retromolar surface
+∞
8.4
8
*
C06.29
ICD-10 Finland
Malignant tumor of the retromolar surface UNS
+∞
8.4
8
*
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
+∞
8.4
8
*
EDC45
NOMESCO Finland
Reconstruction of mandible using bone graft
+∞
8.4
8
*
ECA30
NOMESCO Finland
Excision of lesion of gingiva
18.8
8.3
12
7
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
5.9
8.3
23
46
ECB20
NOMESCO Finland
Oral alveoplasty
35.9
8.2
10
*
WX402
NOMESCO Finland
General anaesthesia
4.0
8.0
34
106
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
10.5
8.0
15
16
WZB00
NOMESCO Finland
Telephone receipt or other advice
3.3
7.9
48
199
PH2CD
NOMESCO Finland
Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity
48.1
7.8
9
*
SPA48
NOMESCO Finland
Precision impression for denture, demanding
48.1
7.8
9
*
GD1AD
NOMESCO Finland
Thorax CT examination
8.0
7.8
17
24
SPF30
NOMESCO Finland
Soling for prothesis
13.0
7.8
13
11
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
5.7
7.8
22
45
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
26.9
7.7
10
*
R13
ICD-10 Finland
Dysphagia
5.9
7.7
21
41
SAA02
NOMESCO Finland
Basic examination of mouth
3.0
7.7
85
522
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
6.2
7.6
20
37
WX730
NOMESCO Finland
Conventional respirator
14.6
7.6
12
9
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
85.0
7.5
8
*
SPA05
NOMESCO Finland
Guiding rail
85.0
7.5
8
*
K12.2
ICD-10 Finland
Cellulitis and abscess of mouth
85.0
7.5
8
*
Z51.5
ICD-10 Finland
Palliative care
5.7
7.4
21
43
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.8
7.4
73
415
A04AD12
ATC
aprepitant; systemic
17.1
7.4
11
7
8070/3-C03.9
ICD-O-3
Squamous cell carcinoma, NOS, of gum, NOS
+∞
7.4
7
*
EKC20
NOMESCO Finland
Plastic repair of cheek
+∞
7.4
7
*
EDW99
NOMESCO Finland
Other operation on mandible
+∞
7.4
7
*
SPA52
NOMESCO Finland
Determination of bite and dental arch location, very demanding
+∞
7.4
7
*
ZZQ40
NOMESCO Finland
Free microvascular graft of bone
+∞
7.4
7
*
SPA02
NOMESCO Finland
Preparation for dental prosthetics
9.7
7.3
14
16
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
21.6
7.3
10
5
L43.9
ICD-10 Finland
Lichen planus, unspecified
32.1
7.3
9
*
EBA10
NOMESCO Finland
Surgical removal of tooth
4.8
7.2
24
59
TPH07
NOMESCO Finland
Cathetrisation of artery
4.0
7.2
30
92
H02AB02
ATC
dexamethasone; systemic
4.2
7.0
27
77
WX707
NOMESCO Finland
Fiberoscopic intubation
42.4
6.8
8
*
SPF11
NOMESCO Finland
Fitting of dental prosthesis
24.0
6.8
9
*
B37.08
ICD-10 Finland
Other candidal stomatitis
24.0
6.8
9
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
9.5
6.7
13
15
Z3226
NOMESCO Finland
Physiotherapist
3.1
6.6
40
164
ZXE20
NOMESCO Finland
More than three and less than five hours
3.4
6.6
33
118
C04.0
ICD-10 Finland
Malignant neoplasm: Anterior floor of mouth
73.5
6.5
7
*
EDA10
NOMESCO Finland
Biopsy of mandible
73.5
6.5
7
*
QAE30
NOMESCO Finland
Excision and repair of surgical scar in head or neck
73.5
6.5
7
*
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
10.1
6.4
12
13
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
7.7
6.4
14
20
ZX095
NOMESCO Finland
Combined chemoradiotherapy
19.2
6.4
9
5
RS240
NOMESCO Finland
NA
+∞
6.3
6
*
K13.22
ICD-10 Finland
Erythroplakia of oral epithelium, including tongue
+∞
6.3
6
*
K08.0
ICD-10 Finland
Exfoliation of teeth due to systemic causes
+∞
6.3
6
*
EEA10
NOMESCO Finland
Biopsy of maxilla
+∞
6.3
6
*
EEW99
NOMESCO Finland
Other operation on maxilla
+∞
6.3
6
*
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
9.4
6.2
12
14
A04AA55
ATC
palonosetron, combinations; systemic
9.4
6.2
12
14
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.2
6.1
18
39
A04AA01
ATC
ondansetron; systemic, rectal
4.9
6.1
19
44

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026389) Candida sp identified in Specimen by Organism specific culture
31
15
26.47
42.06
1.7
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
38
5
104.21
36.02
5.3
2.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
95
360
6.44
24.55
3.5
2.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
82
274
6.02
24.50
3.2
2.7
—
—
—
0
0
(4035726)
51
111
6.75
24.39
1.9
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
106
447
7.22
24.10
4.7
2.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
60
168
5.60
21.53
7.0
5.4
mmol/l
0.9
1.0
1.85
60
150
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
105
520
5.47
17.46
4.6
4.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
64
222
4.56
17.01
5.5
3.0
mmol/l
0.8
0.8
1.91
64
205
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
19
23
9.44
14.88
1.2
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
43
136
4.16
12.44
1.6
1.8
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
20
33
6.93
12.04
1.8
2.2
mg/l
1.1
1.8
3.33
20
28
(3015377) Calcium [Moles/volume] in Serum or Plasma
80
393
3.52
11.78
5.2
3.4
mmol/l
2.4
2.3
0.84
73
340
(3032080) INR in Blood by Coagulation assay
91
511
3.36
10.27
6.3
8.8
inr
1.1
1.2
3.15
16
143
(3003694) ABO and Rh group [Type] in Blood
59
258
3.27
10.19
1.3
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
10
10.71
8.75
1.2
1.8
—
—
—
0
0
(3002256) Pathology report gross observation
36
126
3.53
8.74
1.7
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
92
602
2.63
6.52
7.4
7.1
mmol/l
1.2
1.2
0.38
77
499
(3042936) Bacteria identified in Isolate by Culture
41
186
2.72
6.20
2.3
2.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
87
563
2.51
6.18
6.8
6.0
mmol/l
1.2
1.2
0.02
80
508
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
34
140
2.90
6.15
3.4
5.1
u/l
202.2
250.3
3.10
34
134
(3013650) Neutrophils [#/volume] in Blood by Automated count
93
637
2.45
5.59
12.2
9.6
e9/l
4.4
4.3
0.16
82
560
(42870588) Differential panel, method unspecified - Blood
63
370
2.31
5.35
6.3
5.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
34
151
2.67
5.29
2.1
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
73
464
2.24
5.05
2.2
2.3
nmol/l
74.8
78.1
0.42
68
403
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
21
76
3.09
4.70
7.9
7.2
mmol/l
25.2
24.5
0.34
21
76
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
59
369
2.06
4.01
2.5
2.8
u/l
25.7
33.4
2.58
59
350
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
11
7.64
3.91
1.0
1.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
111
896
2.30
3.55
10.0
7.7
u/l
79.5
78.3
0.16
104
840
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
37
3.46
3.43
1.6
2.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
40
229
2.06
3.37
3.6
3.5
ng/l
235.1
141.0
0.24
34
204
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
33
3.54
3.27
1.6
1.9
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
70
491
1.88
3.23
6.7
6.0
%
0.6
0.6
0.31
64
455
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
21
95
2.43
3.09
2.2
3.9
ml/min/173m2
76.9
58.1
—
7
46
(3006315) Basophils [#/volume] in Blood
75
546
1.83
3.00
6.4
5.9
e9/l
0.0
0.0
0.52
65
471
(3023368) Bacteria identified in Blood by Culture
55
365
1.85
2.96
4.5
4.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
72
520
1.82
2.94
2.4
2.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
16
65
2.66
2.91
1.5
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
76
561
1.80
2.86
6.9
6.2
e9/l
0.2
0.2
0.05
69
495
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
62
432
1.80
2.82
2.8
3.1
ng/l
1120.1
1497.9
0.37
53
360
(3018418) pH of Serum or Plasma
57
388
1.81
2.80
3.8
4.1
ph
7.4
7.4
—
8
76
(3001604) Monocytes [#/volume] in Blood
74
545
1.78
2.78
6.5
5.9
e9/l
0.6
0.6
0.24
64
467
(3006504) Eosinophils/100 leukocytes in Blood
70
508
1.78
2.76
6.8
6.1
%
2.9
2.7
0.36
64
468
(3019198) Lymphocytes [#/volume] in Blood
75
556
1.78
2.74
6.4
5.9
e9/l
1.9
1.8
0.10
68
492
(40758558) Short blood count panel - Blood
45
287
1.85
2.71
9.8
7.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
71
522
1.75
2.64
7.0
6.3
%
23.1
26.2
1.05
65
481
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
123
1076
2.50
2.63
28.8
17.1
mg/l
44.3
24.8
3.13
114
885
(3019069) Monocytes/100 leukocytes in Blood
70
513
1.75
2.63
7.4
6.4
%
9.3
8.7
0.73
64
480
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
38
232
1.89
2.61
3.7
3.2
mmol/l
2.5
2.5
0.24
33
203
(3018010) Neutrophils/100 leukocytes in Blood
70
514
1.75
2.60
6.5
6.0
%
61.6
58.4
0.98
64
478
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
19
3.82
2.18
1.1
1.6
ug/l
13.8
18.1
—
7
19
(3036481) Cortisol [Moles/volume] in Serum or Plasma
20
104
2.08
2.14
3.4
2.2
nmol/l
437.4
369.1
0.75
20
93
(3019225) pH of Specimen
20
105
2.06
2.09
2.6
4.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
18
92
2.10
2.01
1.2
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
17
88
2.06
1.84
1.5
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
31
199
1.72
1.78
1.4
2.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
30
439
0.59
1.73
3.6
4.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
20
113
1.90
1.72
2.3
2.7
u/l
39.7
37.5
0.05
15
89
(40761511) CBC panel - Blood by Automated count
123
1117
2.06
1.71
24.1
16.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
70
2.11
1.66
1.4
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
97
830
1.59
1.63
4.3
4.4
mm/h
18.4
13.9
1.63
91
756
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
14
3.66
1.63
1.0
1.9
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
14
3.66
1.63
1.0
1.9
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
14
3.66
1.63
1.0
1.9
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
14
3.66
1.63
1.0
1.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
14
3.66
1.63
1.2
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
125
1148
2.10
1.57
30.2
19.9
mmol/l
138.7
139.6
2.73
119
1115
(3041096) Erythrocytes [Presence] in Urine by Automated
19
307
0.56
1.56
2.9
4.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
17
94
1.92
1.55
2.0
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
22
133
1.78
1.54
3.0
4.6
ug/l
2.8
37.9
0.60
16
115
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
15
3.42
1.53
1.0
1.9
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
15
3.42
1.53
1.0
1.9
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
6
21
2.94
1.52
1.2
1.4
mmol/l
79.7
66.8
—
6
21
(3023103) Potassium [Moles/volume] in Serum or Plasma
125
1151
2.06
1.51
30.3
19.9
mmol/l
4.0
4.0
0.03
119
1117
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
37
2.53
1.51
1.1
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
106
936
1.60
1.45
27.5
17.7
%
36.8
39.3
2.23
70
614
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
22
136
1.74
1.43
4.8
3.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
12
60
2.10
1.43
1.3
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
17
3.01
1.37
1.0
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
5
17
3.01
1.37
6.6
4.1
u/ml
25.4
58.8
—
5
17
(3021589) Normoblasts [#/volume] in Blood
61
487
1.46
1.34
11.4
11.1
e9/l
0.0
0.0
0.54
49
397
(3019230) Fractional oxyhemoglobin in Venous blood
5
18
2.84
1.29
1.6
2.3
%
58.8
63.9
—
5
18
(3020682) Albumin/Creatinine [Ratio] in Urine
27
380
0.64
1.26
3.2
4.0
mg/mmol
3.1
9.3
1.90
15
244
(46235355) HIV 1 and 2 tests - Meaningful Use set
18
110
1.73
1.23
1.2
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
5
19
2.69
1.22
1.0
1.8
—
2.8
—
0
8
(3012516) Albumin [Mass/volume] in Urine
25
354
0.64
1.19
2.9
3.3
mg/l
39.9
400.5
0.85
18
236
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
33
0.00
1.18
0.0
1.2
—
1.1
—
0
33
(3000991) Gas panel - Venous blood
18
112
1.70
1.16
16.2
8.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
45
559
0.71
1.07
3.1
4.2
estimate
0.0
0.0
—
7
118
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
97
1063
0.69
1.06
4.1
4.9
mmol/l
4.6
4.5
0.33
87
960
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
113
1038
1.52
1.03
25.8
16.0
ml/min/173m2
82.8
74.9
4.69
106
845
(42529406) Shigella sp [Presence] in Stool by Culture
7
35
2.05
1.01
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
35
2.05
1.01
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
35
2.05
1.01
1.3
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
28
0.00
0.99
0.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
28
0.00
0.99
0.0
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
23
318
0.67
0.97
4.0
4.4
estimate
0.0
0.0
—
6
111
(40768443) Skin Pathology biopsy report
9
51
1.82
0.96
1.1
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
32
0.00
0.96
0.0
1.2
—
0.2
—
0
32
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
60
500
1.36
0.96
2.1
2.0
pmol/l
96.4
93.4
0.15
31
243
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
14
86
1.70
0.95
1.3
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
97
1055
0.72
0.91
3.9
4.8
mmol/l
1.5
1.4
0.10
82
943
(3007461) Platelets [#/volume] in Blood
125
1182
1.71
0.91
38.0
24.8
e9/l
258.9
242.6
1.59
117
1150
(3035941) MCH [Entitic mass]
125
1183
1.70
0.89
37.8
24.6
pg
30.6
30.4
0.58
119
1165
(3026361) Erythrocytes [#/volume] in Blood
125
1183
1.70
0.89
38.0
24.8
e12/l
4.0
4.5
11.54
116
1144
(3024731) MCV [Entitic volume]
125
1183
1.70
0.89
37.9
24.7
fl
92.6
91.6
1.64
119
1165
(3000963) Hemoglobin [Mass/volume] in Blood
125
1183
1.70
0.89
38.2
24.9
g/l
122.3
134.9
11.97
119
1163
(3010813) Leukocytes [#/volume] in Blood
125
1183
1.70
0.89
38.0
24.8
e9/l
7.5
6.8
1.26
117
1146
(3021601) Nitrite [Presence] in Urine by Test strip
46
556
0.74
0.88
4.0
5.7
estimate
0.0
0.0
—
6
116
(3041354) Potassium [Moles/volume] in Venous blood
0
24
0.00
0.80
0.0
2.6
—
4.0
—
0
24
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
24
0.00
0.80
0.0
2.6
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
24
0.00
0.80
0.0
2.6
—
107.6
—
0
24
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
26
0.00
0.79
0.0
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
75
1.66
0.78
17.6
7.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
34
1.80
0.77
1.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
23
2.22
0.77
1.2
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
24
178
1.42
0.75
11.9
7.1
mmol/l
103.6
103.7
0.01
24
171
(3024928) Oxygen saturation in Venous blood
5
25
2.04
0.73
1.6
2.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
40
1.79
0.72
1.6
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
102
1090
0.74
0.72
4.4
5.5
mmol/l
2.7
2.6
0.29
89
976
(3009261) Glucose [Presence] in Urine by Test strip
48
564
0.77
0.72
3.1
4.2
estimate
0.0
0.0
—
7
110
(3002173) Hemoglobin [Mass/volume] in Arterial blood
19
136
1.46
0.71
15.9
7.8
g/l
114.8
120.4
0.72
19
129
(3044889) 12 lead EKG panel
88
798
1.29
0.69
4.6
4.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
5
95
0.51
0.69
9.6
6.3
mmol/l
25.8
25.0
—
5
86
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
30
236
1.35
0.68
1.7
1.7
mg/l
1.7
1.6
0.03
24
197
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
28
1.81
0.67
1.4
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
44
1.62
0.66
1.3
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
6
101
0.58
0.65
6.3
3.9
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
5
29
1.75
0.64
2.4
1.4
%
84.4
85.2
—
5
29
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
15
105
1.48
0.63
1.6
3.6
ng/l
43.4
80.8
—
10
93
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
21
0.00
0.60
0.0
3.1
—
1265.4
—
0
5
(3019309) Folate [Moles/volume] in Red Blood Cells
33
269
1.30
0.59
2.0
1.7
nmol/l
921.1
1197.2
1.14
24
204
(3016502) Oxygen saturation in Arterial blood
20
151
1.38
0.58
15.3
7.4
%
97.8
95.8
3.97
20
143
(3000492) Spirometry study
13
91
1.47
0.55
1.2
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
35
291
1.27
0.54
2.1
2.1
mg/l
2.5
3.2
1.48
27
256
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
47
1.52
0.48
1.6
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
95
888
1.23
0.48
30.3
20.6
%
14.3
13.9
1.01
89
875
(3020564) Creatinine [Moles/volume] in Serum or Plasma
120
1154
1.34
0.45
32.9
20.3
umol/l
73.0
81.8
4.14
120
1154
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
43
489
0.82
0.44
3.9
5.1
ug/l
1.8
2.8
0.79
31
432
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
32
1.58
0.42
1.0
1.5
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
5
33
1.53
0.42
2.0
2.6
kpa
4.6
4.9
—
5
33
(3027315) Oxygen [Partial pressure] in Blood
5
33
1.53
0.42
2.0
2.6
kpa
7.4
8.0
—
5
33
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
9
125
0.70
0.37
2.2
4.2
mmol/l
6.2
1.8
—
9
98
(3045414) Leukocytes [Presence] in Urine
6
42
1.45
0.36
1.7
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
18
145
1.28
0.36
1.4
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
29
335
0.83
0.35
2.4
3.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
109
1048
1.20
0.32
5.1
6.4
mmol/mol
38.3
41.3
4.02
100
970
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
98
0.70
0.32
1.6
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
85
803
1.16
0.31
4.2
3.8
pmol/l
14.9
15.1
0.29
75
702
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
49
445
1.16
0.31
3.3
3.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
34
383
0.85
0.31
3.7
4.5
%
21.3
21.3
—
10
197
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
7
55
1.29
0.30
1.7
3.2
u/ml
5.4
178.6
—
7
48
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
25
289
0.83
0.30
2.5
2.9
ug/l
0.6
0.7
0.55
12
197
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
119
1157
1.23
0.28
13.5
11.3
u/l
21.0
25.4
4.57
110
1110
(3031040) Bacteria [#/volume] in Urine by Automated count
80
756
1.14
0.28
4.6
5.1
—
3682.0
—
0
17
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
8
65
1.24
0.27
2.4
3.9
mmol/l
28.0
23.9
—
8
59
(3022145) Colonoscopy Study observation
11
137
0.79
0.25
1.2
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
10
126
0.78
0.25
2.4
4.2
kpa
6.8
5.7
—
10
121
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
99
1025
0.87
0.24
3.6
4.3
mmol/l
1.3
1.3
0.04
86
911
(3012544) pH of Venous blood
10
125
0.78
0.24
2.4
4.2
—
—
—
0
0
(3010421) pH of Blood
5
39
1.29
0.23
2.0
2.7
ph
7.4
7.4
—
5
33
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
39
1.29
0.23
1.0
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
41
1.23
0.22
2.8
4.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
19
164
1.18
0.22
1.4
1.3
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
413.7
—
0
6
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
41.6
—
0
5
(3004775) Volume in Urine collected for unspecified duration
0
11
0.00
0.21
0.0
2.4
—
400.2
—
0
5
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
297.0
—
0
5
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(4281824)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
12
0.00
0.21
0.0
3.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
13
0.00
0.21
0.0
4.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
17
146
1.19
0.20
7.7
8.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
6
50
1.21
0.20
1.2
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
22
195
1.15
0.19
3.5
3.2
e6/l
5.0
2.5
0.42
13
106
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
17
148
1.17
0.18
1.4
1.9
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
5
66
0.75
0.17
1.6
2.7
%
0.7
0.7
—
5
66
(40761535) Cells panel - Urine sediment
12
101
1.21
0.17
3.4
3.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
104
1066
0.90
0.16
4.5
5.1
mmol/l
5.9
6.1
0.76
92
957
(3002582) Erythrocytes [#/volume] in Urine
41
384
1.10
0.15
3.6
3.5
e6/l
46.7
214.4
0.49
36
294
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
13
112
1.18
0.15
3.5
2.8
ug/l
3.7
7.8
1.31
13
102
(3013512) EKG study
40
375
1.09
0.14
6.2
4.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
101
987
1.09
0.13
5.4
4.7
mu/l
2.0
2.0
0.11
86
869
(3022621) pH of Urine by Test strip
10
85
1.19
0.12
1.7
2.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
116
0.85
0.12
1.1
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
40
379
1.08
0.11
2.8
3.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
25
232
1.10
0.10
4.0
5.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
18
197
0.90
0.10
1.3
1.4
g/l
1.8
2.8
—
7
117
(3022948) Iron [Moles/volume] in Serum or Plasma
22
203
1.10
0.10
1.8
2.3
umol/l
11.1
13.1
0.57
22
186
(3011397) Hemoglobin [Presence] in Urine by Test strip
25
267
0.92
0.09
3.2
3.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
54
1.12
0.09
1.3
2.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
45
433
1.06
0.08
4.2
4.0
e6/l
122.2
57.1
0.49
35
318
(3004119) Hemoglobin [Mass/volume] in Venous blood
8
78
1.03
0.07
1.8
3.9
g/l
122.5
123.2
—
8
78
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
8
91
0.87
0.07
1.3
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
9
103
0.86
0.06
3.3
4.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
76
773
0.96
0.05
4.5
4.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
20
190
1.06
0.04
1.8
2.3
g/l
2.0
2.3
1.68
20
172
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
49
499
0.97
0.02
4.5
4.5
ng/l
20.4
37.3
2.86
38
386
(36304419) Bacteria [Presence] in Urine
35
342
1.03
0.02
3.3
3.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
10
107
0.93
0.02
2.0
3.0
kpa
4.4
4.2
—
10
102
(3004588) Protein electrophoresis panel - Serum or Plasma
11
104
1.06
0.01
1.6
1.6
—
—
—
0
0
(4010399)
8
81
0.99
0.00
1.1
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
7
70
1.00
0.00
1.0
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
1146.0
—
0
6
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
22
220
1.00
0.00
2.8
2.9
e6/l
1.6
1.1
0.26
13
130
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.1
—
6.4
—
0
7
(4024509)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
19.2
—
0
9
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
59
0.84
0.00
2.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.6
—
207.6
—
0
5
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
8
0.00
0.00
0.0
1.3
—
155.4
—
0
8
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(4146454)
0
8
0.00
0.00
0.0
3.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
1.1
—
0
7
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
4.6
—
49.6
—
0
5
(3026470) Cobalt [Mass/volume] in Blood
0
8
0.00
0.00
0.0
1.9
—
2.7
—
0
8
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
2.0
—
0
8
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
1.2
—
0
5
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
5
54
0.92
0.00
4.0
3.0
pmol/l
4.1
4.5
—
5
46
(3000330) Specific gravity of Urine by Test strip
6
68
0.88
0.00
1.8
4.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
7
0.00
0.00
0.0
2.1
—
2406.4
—
0
7

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_GUM – Malignant neoplasm of gum

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).